Literature DB >> 20429487

Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town.

Priya Batra1, Louise Kuhn, Lynette Denny.   

Abstract

OBJECTIVE: An audit of outcomes of cervical cancer screening and prevention services for HIV-positive women in Cape Town, South Africa.
DESIGN: Retrospective review of clinic registers, patient records and pathology databases at three HIV primary health clinics and a tertiary colposcopy referral centre.
SUBJECTS: Women recently diagnosed with HIV at three primary health clinics between 2006 and 2008 (N=2 240); new patients seen for colposcopy at a tertiary referral centre between 2006 and 2009 (N=2 031). OUTCOME MEASURES: The proportion of women undergoing cervical cancer screening after HIV diagnosis at primary health clinics, demographic characteristics of women referred for colposcopy at a tertiary centre, and outcomes of therapy for precancerous lesions of the cervix.
RESULTS: The proportion of women undergoing at least one Pap smear at HIV primary health clinics after HIV diagnosis was low (13.1%). Women referred for colposcopy tended to be HIV-positive and over the age of 30 years, and in most (70.2%) cytological examination revealed high-grade cervical dysplasia. HIV-positive women treated with excision for precancerous lesions of the cervix were significantly more likely than their HIV-negative counterparts to undergo incomplete excision, experience persistent cervical disease after treatment, and be lost to follow-up.
CONCLUSION: Cervical cancer screening efforts must be scaled up for women with HIV. Treatment and surveillance guidelines for cervical intraepithelial neoplasia in HIV-positive women may need to be revised and new interventions developed to reduce incomplete treatment and patient default.

Entities:  

Mesh:

Year:  2010        PMID: 20429487

Source DB:  PubMed          Journal:  S Afr Med J


  7 in total

1.  Knowledge of HPV among HIV-Infected and HIV-Uninfected Adolescent Women in South Africa.

Authors:  David C Griffith; David Adler; Melissa Wallace; Thola Bennie; Beau Abar; Linda-Gail Bekker
Journal:  J Womens Health Issues Care       Date:  2015-09-23

2.  Integrating cervical cancer prevention initiatives with HIV care in resource-constrained settings: A formative study in Durban, South Africa.

Authors:  Katie A Ports; Firoza Haffejee; Maghboeba Mosavel; Anjali Rameshbabu
Journal:  Glob Public Health       Date:  2015-02-05

3.  Awareness of cervical cancer among women attending an HIV treatment centre: a cross-sectional study from Morocco.

Authors:  Essaada Belglaiaa; Tiatou Souho; Latifa Badaoui; Michel Segondy; Jean-Luc Prétet; David Guenat; Christiane Mougin
Journal:  BMJ Open       Date:  2018-08-23       Impact factor: 2.692

4.  The impact of decentralising colposcopy services from tertiary-level to primary-level care in inner-city Johannesburg, South Africa: a before and after study.

Authors:  Gloria Maimela; Xolisile Nene; Nontuthuko Mvundla; Shobna Sawry; Trudy Smith; Helen Rees; Elizabeth Kachingwe; Matthew Chersich
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

5.  Willingness and acceptability of cervical cancer screening among HIV positive Nigerian women.

Authors:  Oliver C Ezechi; Chidinma V Gab-Okafor; Per Olof Ostergren; Karen Odberg Pettersson
Journal:  BMC Public Health       Date:  2013-01-17       Impact factor: 3.295

6.  Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign.

Authors:  Sinead Delany-Moretlwe; Karen F Kelley; Shamagonam James; Fiona Scorgie; Hasina Subedar; Nonhlanhla R Dlamini; Yogan Pillay; Nicolette Naidoo; Admire Chikandiwa; Helen Rees
Journal:  Glob Health Sci Pract       Date:  2018-10-04

7.  Knowledge, attitude, and practice of cervical cancer screening among women living with HIV in the Kilimanjaro region, northern Tanzania.

Authors:  Faustini C Kimondo; Happiness D Kajoka; Meshack R Mwantake; Caroline Amour; Innocent B Mboya
Journal:  Cancer Rep (Hoboken)       Date:  2021-03-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.